pre-IPO PHARMA

COMPANY OVERVIEW

Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Oncology
  • Rare Diseases

  • WEBSITE

    https://www.dauntlessph.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    canaan-partners sofinnova-investments


    PRESS RELEASES


    May 4, 2017

    Dauntless Pharmaceuticals Announces Positive Data from Phase 1 Study Investigating Octreotide Formulation for Intranasal Delivery


    Feb 16, 2017

    Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery


    Jul 21, 2015

    Dauntless Pharmaceuticals Launches New Company Focused on Developing a Portfolio of Improved Therapeutics


    Jul 21, 2015

    Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement


    For More Press Releases


    Google Analytics Alternative